Literature DB >> 2542722

Dietary fish oils increase serum lipids in insulin-dependent diabetics compared with healthy controls.

T A Mori1, R Vandongen, J R Masarei, K G Stanton, D Dunbar.   

Abstract

The effect of daily dietary supplementation with fish oil on serum lipids and platelet total phospholipid fatty acids was examined in male normolipidemic insulin-dependent diabetics and normal controls. They were given 15 g/d of fish oil as Max EPA (equivalent to 2.7 g/d of eicosapentaenoic acid) for 3 weeks. The diabetics showed a rise in total cholesterol, attributable to increases in LDL- and HDL-cholesterol. The increase in HDL-cholesterol was largely due to a rise in its HDL2 subclass. There was also a decrease in triglycerides in both groups. Similar changes in lipids were seen in the normal controls, although these were not significant. The more pronounced effect in diabetics suggests an altered metabolic response to omega-3 fatty acids in that disorder. However, the results indicate that the possible detrimental effect of the rise in total and LDL-cholesterol following fish oil may be offset by the increase in the protective HDL2 subclass.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542722     DOI: 10.1016/0026-0495(89)90188-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Modulation of lipid profile by fish oil and garlic combination.

Authors:  N C Morcos
Journal:  J Natl Med Assoc       Date:  1997-10       Impact factor: 1.798

Review 2.  Atherogenic profiles in insulin-dependent diabetic patients and their treatment.

Authors:  I De Leeuw
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

3.  Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study).

Authors:  Ville-Petteri Mäkinen; Tuulia Tynkkynen; Pasi Soininen; Carol Forsblom; Tomi Peltola; Antti J Kangas; Per-Henrik Groop; Mika Ala-Korpela
Journal:  Metabolomics       Date:  2011-08-05       Impact factor: 4.290

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.